MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis

Acta Haematologica

Volumn 129, Issue 4, 2013, Pages 251-256

  Gebauer, Niklas ^a,c   Bernard, Veronica ^a   Gebauer, Wolfgang ^b   Feller, Alfred C ^a   Merz, Hartmut ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b KLINIKUM OLDENBURG   (Germany)

^c Moislinger Allee   (Germany)

Author keywords

Chronic idiopathic myelofibrosis; Essential thrombocythemia; MicroRNAs; Myeloproliferative disorders; Polycythemia vera

Indexed keywords

JANUS KINASE 2; MICRORNA; MICRORNA 182; MIRNA 10A; MIRNA 150; MIRNA 342; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MICRORNA 10A; MICRORNA 150; MICRORNA 342;

ALLELE; ARTICLE; BONE MARROW BIOPSY; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; LEUKOCYTE COUNT; MYELOID METAPLASIA; MYELOPOIESIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTHEMIA; DIFFERENTIAL DIAGNOSIS; HEMATOPOIESIS; HUMAN; HUMAN TISSUE; JAK2 GENE; PATHOGENESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ALLELES; GENE EXPRESSION REGULATION; HUMANS; JANUS KINASE 2; MICRORNAS; MUTATION; PHILADELPHIA CHROMOSOME; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84872795166     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000345848     Document Type: Article

References (21)

1. Thiele J, Kvasnicka HM, Orazi A: Bone marrow histopathology in myeloproliferative disorders-current diagnostic approach. Semin Hematol 2005; 42: 184-195.
2. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garcon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144-1148.
3. Lea NC, Lim Z, Westwood NB, Arno MJ, Gaken J, Mohamedali A, Mufti GJ: Presence of JAK2 V617F tyrosine kinase mutation as a myeloid-lineage-specific mutation in chronic neutrophilic leukaemia. Leukemia 2006; 20: 1324-1326.
4. Ceesay MM, Lea NC, Ingram W, Westwood NB, Gaken J, Mohamedali A, Cervera J, Germing U, Gattermann N, Giagounidis A, Garcia-Casado Z, Sanz G, Mufti GJ: The JAK2 V617F mutation is rare in RARS but common in RARS-T. Leukemia 2006; 20: 2060-2061.
5. Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A: Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007; 21: 1960-1963.
6. Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, Ferrari M, Gisslinger H, Kralovics R, Cremonesi L, Skoda R, Cazzola M: Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008; 111: 1686-1689.
7. Thiele J, Kvasnicka HM, Mullauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H: Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification. Blood 2011; 117: 5710-5718.
8. WHO Classification of Tumors of Haematopoetic and Lymphoid Tissues, ed 4. Geneva, WHO, 2008.
9. Bock O, Neuse J, Hussein K, Brakensiek K, Buesche G, Buhr T, Wiese B, Kreipe H: Aberrant collagenase expression in chronic idiopathic myelofibrosis is related to the stage of disease but not to the JAK2 mutation status. Am J Pathol 2006; 169: 471-481.
10. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT: Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol 2007; 35: 1657-1667.
11. Bruchova H, Merkerova M, Prchal JT: Aberrant expression of microRNA in polycythemia vera. Haematologica 2008; 93: 1009-1016.
12. Guglielmelli P, Tozzi L, Pancrazzi A, Bogani C, Antonioli E, Ponziani V, Poli G, Zini R, Ferrari S, Manfredini R, Bosi A, Vannucchi AM: MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol 2007; 35: 1708-1718.
13. Hussein K, Dralle W, Theophile K, Kreipe H, Bock O: Megakaryocytic expression of miRNA 10a, 17-5p, 20a and 126 in Philadelphia chromosome-negative myeloproliferative neoplasm. Ann Hematol 2009; 88: 325-332.
14. Debernardi S, Skoulakis S, Molloy G, Chaplin T, Dixon-McIver A, Young BD: MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia 2007; 21: 912-916.
15. Agirre X, Jimenez-Velasco A, San Jose-Eneriz E, Garate L, Bandres E, Cordeu L, Aparicio O, Saez B, Navarro G, Vilas-Zornoza A, Perez-Roger I, Garcia-Foncillas J, Torres A, Heiniger A, Calasanz MJ, Fortes P, Roman-Gomez J, Prosper F: Down-regulation of hsamiR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6: 1830-1840.
16. Okada Y, Matsuura E, Tozuka Z, Nagai R, Watanabe A, Matsumoto K, Yasui K, Jackman RW, Nakano T, Doi T: Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes. Blood 2004; 104: 2027-2034.
17. Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T, Valera S, Rozman M, Belkaid M, Montserrat E, Monzo M: Hematopoiesisrelated microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 2009; 50: 1854-1859.
18. Hussein K, Busche G, Muth M, Gohring G, Kreipe H, Bock O: Expression of myelopoiesis-associated microRNA in bone marrow cells of atypical chronic myeloid leukaemia and chronic myelomonocytic leukaemia. Ann Hematol 2011; 90: 307-313.
19. Stittrich AB, Haftmann C, Sgouroudis E, Kuhl AA, Hegazy AN, Panse I, Riedel R, Flossdorf M, Dong J, Fuhrmann F, Heinz GA, Fang Z, Li N, Bissels U, Hatam F, Jahn A, Hammoud B, Matz M, Schulze FM, Baumgrass R, Bosio A, Mollenkopf HJ, Grun J, Thiel A, Chen W, Hofer T, Loddenkemper C, Lohning M, Chang HD, Rajewsky N, Radbruch A, Mashreghi MF: The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat Immunol 2010; 11: 1057-1062.
20. Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Kang T, Huang W: MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 2011; 32: 1033-1042.
21. De Marchis ML, Ballarino M, Salvatori B, Puzzolo MC, Bozzoni I, Fatica A: A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells. Leukemia 2009; 23: 856-862.